Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases

JAMA Dermatol. 2017 Nov 1;153(11):1195-1197. doi: 10.1001/jamadermatol.2017.2392.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Dose-Response Relationship, Drug
  • Female
  • Hidradenitis Suppurativa / diagnosis
  • Hidradenitis Suppurativa / drug therapy*
  • Humans
  • Injections, Subcutaneous
  • Interleukin-1beta
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-1beta
  • canakinumab